Reducing door-to-antibiotic time in community-acquired pneumonia: Controlled before-and-after evaluation and cost-effectiveness analysis

Thorax

Volumn 62, Issue 1, 2007, Pages 67-74

  Barlow, Gavin ^a,b   Nathwani, Dilip ^b   Williams, Fiona ^c   Ogston, Simon ^c   Winter, John ^b   Jones, Michael ^b   Slane, Peter ^b   Myers, Elizabeth ^b   Sullivan, Frank ^c   Stevens, Nicola ^b   Duffey, Rebecca ^c   Lowden, Karen ^b   Davey, Peter ^c  

^a CASTLE HILL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HOSPITAL MANAGEMENT; HOSPITAL PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; OBSERVATIONAL STUDY; PRIORITY JOURNAL; THERAPY DELAY;

AGED; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; COST-BENEFIT ANALYSIS; FEMALE; GUIDELINE ADHERENCE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MEDICAL AUDIT; MIDDLE AGED; PNEUMONIA; PRACTICE GUIDELINES; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 33846267003     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.056689     Document Type: Article

References (20)

1. Guest JF, Morris A. Community-acquired pneumonia: the annual cost to the National Health Service in the UK. Eur Resp J 1997;10:1530- 4.
2. Chu LA, Bratzler DW, Lewis RJ, et al. Improving the quality of care for patients with pneumonia in very small hospitals. Arch Intern Med 2003;163:326-32.
3. Dean NC, Silver MP, Bateman KA, et al. Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia. Am J Med 2001;110:451-7.
4. Marrie TJ, Lau CY, Wheeler SL, et al. A controlled trial of a critical pathway for treatment of community- acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA 2000;283:749-55.
5. Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004;8:1-72.
6. Nathwani D, Williams F, Winter J, et al. Use of indicators to evaluate the quality of community-acquired pneumonia management. Clin Infect Dis 2002;34:318-23.
7. British Thoracic Society. BTS guidelines for the management of community acquired pneumonia in adults. Thorax 2001;56(Suppl 4):1-64.
8. Simpson JCG, Macfarlane JT, Watson J, et al. A national confidential enquiry into community acquired pneumonia deaths in young adults in England and Wales. Thorax 2000;55:1040-5.
9. Houck PM, Bratzler DW, Nsa W, et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004;164:637-44.
10. Battleman DS, Callahan M, Thaler HT. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. Arch Intern Med 2002;162:682-8.
11. Gleason PP, Meehan TP, Fine MJ, et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999;159:2562-72.
12. Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997;278:2080-4.
13. Centers for Medicare & Medicaid Services. The Medicare National Pneumonia National Quality Improvement Project. http://www.medqic.org/ content/nationalpriorities/topics/projectdes.jsp?topicID=445.
14. Cochrane Effective Practice and Organisation of Care (EPOC) Review Group. http://www.epoc.uottawa.ca/checklist2002.doc (accessed 17 Nov 2006).
15. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377-82.
16. Dedier J, Singer DE, Chang Y, et al. Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med 2001;161:2099-104.
17. Silber SH, Garrett C, Singh R, et al. Early administration of antibiotics does not shorten time to clinical stability in patients with moderate-to-severe community-acquired pneumonia. Chest 2003;124:1798-804.
18. Ukoumunne OC, Gulliford MC, Chinn S, et al. Methods in health service research. Evaluation of health interventions at area and organisation level. BMJ 1999;319:376-9.
19. MRC Health Services and Public Health Research Board. A framework for development and evaluation of RCTs for complex interventions to improve health. http://www.mrc.ac.uk/pdf-mrc_cpr.pdf (accessed 17 Nov 2006).
20. Resar R, Pronovost P, Haraden C, et al. Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Jt Comm J Qual Patient Saf 2005;31:243-8.